ANGO Financial Facts
Net sales: 88.1MGeneral and administrative: 8.17M
See Full Income Statement
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY: 726.71M
Accrued liabilities: 19.21M
See Full Balance Sheet
AngioDynamics (ANGO) Earnings
|
Expand Research on ANGO
| Next EPS Date | 7/10/24 *Est. | EPS Growth Rate | -433.3% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +7.7% | Revenue Growth Rate | -18.2% *Last Qtr. |
| Average % Move 1-Wk after EPS | -3.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10/7/10 | Q111 | $0.08 | $0.08 | $0.00 | N/A | N/A | = |  | | Details | |
1/4/11  |
 |
Q211 | $0.13 | $0.12 | +$0.01 | $53.4M | $54.37M | = | | | Details |
| 4/5/11 |
|
Q311 | $0.15 | $0.12 | +$0.03 | $54.6M | $53.89M | = | | | Details |
| 7/14/11 |
|
Q411 | -$0.03 | $0.10 | -$0.13 | $56.4M | $56.96M | = | | | Details |
| 10/6/11 |
|
Q112 | $0.08 | $0.08 | $0.00 | $54.4M | $53.86M | = | | | Details |
| 1/5/12 |
|
Q212 | $0.13 | $0.12 | +$0.01 | $53.4M | $56.26M | = | | | Details |
| 4/4/12 |
|
Q313 | $0.09 | $0.08 | +$0.01 | $51.6M | $51.34M | = | | | Details |
| 7/12/12 |
|
Q412 | $0.10 | $0.09 | +$0.01 | $57.7M | $52.97M | = | | | Details |
